# Conversion to Antipsychotic Monotherapy

> **NCT01368458** · NA · TERMINATED · sponsor: **Nathan Kline Institute for Psychiatric Research** · enrollment: 24 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **OTHER:** Conversion to Antipsychotic Monotherapy

## Key facts

- **NCT ID:** NCT01368458
- **Lead sponsor:** Nathan Kline Institute for Psychiatric Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01368458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01368458, "Conversion to Antipsychotic Monotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01368458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*